Molecular Complexity of Lymphovascular Invasion: The Role of Cell Migration in Breast Cancer as a Prototype
Pathobiology · 2020 · 87 (4) · 218-231
DOI: 10.1159/000508337 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathobiology, online erschienen am 09.07.2020. Verfasst von Yousif A Kariri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham, United Kin…. Hauptthemen laut MEDLINE: Cell Movement. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 115 Literaturangaben.
Abstract (Originalsprache)
Lymphovascular invasion (LVI) is associated with poor outcome in breast cancer (BC); however, its underlying mechanisms remain ill-defined. LVI in BC develops through complex molecular pathways involving not only the interplay with the surrounding microenvironment along with endothelial cells lining the lymphovascular spaces but also changes in the malignant epithelial cells with the acquisition of more invasive and migration abilities. In this review, we focus on the key features that enable tumour cell detachment from the primary niche, their migration and interaction with the surrounding microenvironment as well as the crosstalk with the vascular endothelial cells, which eventually lead to intravasation of tumour cells and LVI. Intravascular tumour cell survival and migration, their distant site extravasation, stromal invasion and growth are part of the metastatic cascade. Cancer cell migration commences with loss of tumour cells’ cohesion initiating the invasion and migration processes which are usually accompanied by the accumulation of specific cellular and molecular changes that enable tumour cells to overcome the blockades of the extracellular matrix, spread into surrounding tissues and interact with stromal cells and immune cells. Thereafter, tumour cells migrate further via interacting with lymphovascular endothelial cells to penetrate the vessel wall leading ultimately to intravasation of cancer cells. Exploring the potential factors influencing cell migration in LVI can help in understanding the underlying mechanisms of LVI to identify targeted therapy in BC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham, United Kingdom.
- Faculty of Applied Medical Science, Shaqra University, Riyadh, Saudi Arabia.
- Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, Nottingham, United Kingdom.
- Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham, United Kingdom, Emad.Rakha@nottingham.ac.uk.
Zitieren
APA
Kariri, Y. A., Aleskandarany, M. A., Joseph, C., Kurozumi, S., Mohammed, O. J., Toss, M. S., Green, A. R., & Rakha, E. A. (2020). Molecular Complexity of Lymphovascular Invasion: The Role of Cell Migration in Breast Cancer as a Prototype. Pathobiology, 87(4), 218-231. https://doi.org/10.1159/000508337
Vancouver
Kariri YA, Aleskandarany MA, Joseph C, Kurozumi S, Mohammed OJ, Toss MS, et al. Molecular Complexity of Lymphovascular Invasion: The Role of Cell Migration in Breast Cancer as a Prototype. Pathobiology. 2020;87(4):218-231. doi:10.1159/000508337
BibTeX
@article{Kariri2020,
author = {Kariri, Yousif A and Aleskandarany, Mohammed A and Joseph, Chitra and Kurozumi, Sasagu and Mohammed, Omar J and Toss, Michael S and Green, Andrew R and Rakha, Emad A},
title = {Molecular Complexity of Lymphovascular Invasion: The Role of Cell Migration in Breast Cancer as a Prototype},
journal = {Pathobiology},
year = {2020},
volume = {87},
number = {4},
pages = {218--231},
doi = {10.1159/000508337}
}
EUVIMED